Untangling the complex web of US drug pricing — with AJ Loiacono

Drug prices are a major topic of conversation these days as the Biden administration grapples with federal options for mitigating what many see as out of control costs for specialty drugs. To put some context to the news, HIMSSCast host and Healthcare Finance News Managing Editor Susan Morse welcome to the show AJ Loiacono, CEO of Capital Rx, to talk a bit about why drug pricing is the way it is and what can be done.Talking points:Why are drug prices so poorly defined for doctors and patients...